Stratos Wealth Partners, Ltd. Abbott Laboratories Transaction History

Stratos Wealth Partners, Ltd.

$6.79 Billion
Q3 2024

A detailed history of Stratos Wealth Partners, Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 117,370 shares of ABT stock, worth $13.2 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

117,370

Previous 113,009 3.86%

Holding current value

$13.2 Million

Previous $11.7 Million 13.96%

% of portfolio

0.2%

Previous 0.19%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$100.07 - $118.13 $436,405 - $515,164	4,361 Added 3.86%	117,370 $13.4 Million
Q2 2024 Jul 24, 2024	SELL	$100.73 - $112.44 $906,066 - $1.01 Million	-8,995 Reduced 7.37%	113,009 $11.7 Million
Q1 2024 Apr 16, 2024	SELL	$109.52 - $120.96 $1.21 Million - $1.33 Million	-11,005 Reduced 8.27%	122,004 $13.9 Million
Q4 2023 Jan 24, 2024	SELL	$90.19 - $110.4 $8,477 - $10,377	-94 Reduced 0.07%	133,009 $14.6 Million
Q3 2023 Oct 24, 2023	BUY	$95.53 - $114.62 $537,833 - $645,310	5,630 Added 4.42%	133,103 $12.9 Million
Q2 2023 Jul 18, 2023	BUY	$100.78 - $112.29 $945,114 - $1.05 Million	9,378 Added 7.94%	127,473 $13.9 Million
Q1 2023 Apr 27, 2023	SELL	$96.86 - $114.01 $617,579 - $726,927	-6,376 Reduced 5.12%	118,095 $12 Million
Q4 2022 Jan 19, 2023	SELL	$95.06 - $111.52 $465,889 - $546,559	-4,901 Reduced 3.79%	124,471 $0
Q3 2022 Oct 24, 2022	SELL	$96.76 - $112.03 $571,174 - $661,313	-5,903 Reduced 4.36%	129,372 $12.5 Million
Q2 2022 Jul 22, 2022	BUY	$102.07 - $123.37 $93,394 - $112,883	915 Added 0.68%	135,275 $14.7 Million
Q1 2022 Apr 26, 2022	BUY	$114.02 - $139.04 $625,057 - $762,217	5,482 Added 4.25%	134,360 $15.9 Million
Q4 2021 Jan 14, 2022	SELL	$115.53 - $141.46 $370,273 - $453,379	-3,205 Reduced 2.43%	128,878 $18.1 Million
Q3 2021 Oct 19, 2021	BUY	$116.66 - $129.06 $169,740 - $187,782	1,455 Added 1.11%	132,083 $15.6 Million
Q2 2021 Jul 19, 2021	SELL	$105.79 - $124.53 $9,097 - $10,709	-86 Reduced 0.07%	130,628 $15.1 Million
Q1 2021 Apr 27, 2021	BUY	$108.84 - $128.23 $185,136 - $218,119	1,701 Added 1.32%	130,714 $15.7 Million
Q4 2020 Jan 29, 2021	BUY	$105.0 - $114.42 $926,100 - $1.01 Million	8,820 Added 7.34%	129,013 $14.1 Million
Q3 2020 Oct 29, 2020	BUY	$91.64 - $111.29 $2.22 Million - $2.7 Million	24,268 Added 25.3%	120,193 $13.1 Million
Q2 2020 Jul 28, 2020	BUY	$76.57 - $98.0 $684,612 - $876,218	8,941 Added 10.28%	95,925 $8.77 Million
Q1 2020 May 04, 2020	BUY	$62.82 - $91.86 $901,341 - $1.32 Million	14,348 Added 19.75%	86,984 $6.86 Million
Q4 2019 Jan 29, 2020	BUY	$78.51 - $87.4 $122,004 - $135,819	1,554 Added 2.19%	72,636 $6.31 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $5.79 Million - $6.28 Million	70,785 Added 23833.33%	71,082 $5.95 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $5.45 Million - $5.91 Million	-66,597 Reduced 99.56%	297 $7.17 Million
Q2 2019 Aug 06, 2019	SELL	$72.88 - $85.0 $105,894 - $123,505	-1,453 Reduced 2.13%	66,894 $5.63 Million
Q1 2019 May 07, 2019	BUY	$66.22 - $80.06 $62,180 - $75,176	939 Added 1.39%	68,347 $5.46 Million
Q4 2018 Feb 08, 2019	BUY	$65.56 - $74.27 $4.42 Million - $5.01 Million	67,408 New	67,408 $4.88 Million
Q3 2018 Nov 02, 2018	SELL	$60.81 - $73.36 $3.92 Million - $4.73 Million	-64,531 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $35,866 - $39,585	-623 Reduced 0.96%	64,531 $3.94 Million
Q1 2018 May 10, 2018	BUY	$56.27 - $63.62 $265,144 - $299,777	4,712 Added 7.8%	65,154 $3.9 Million
Q4 2017 Feb 09, 2018	SELL	$53.68 - $57.47 $105,910 - $113,388	-1,973 Reduced 3.16%	60,442 $3.45 Million
Q3 2017 Nov 07, 2017	BUY	$48.06 - $53.64 $3 Million - $3.35 Million	62,415	62,415 $3.33 Million

Others Institutions Holding ABT

# of Institutions

3,189

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Account

Stratos Wealth Partners, Ltd. Abbott Laboratories Transaction History